Stockscreener 앱 받기
0.3499
0.03%
-0.000100
시간 외 거래:
.38
0.0301
+8.60%
전일 마감가:
$0.35
열려 있는:
$0.35
하루 거래량:
133.61K
Relative Volume:
1.56
시가총액:
$5.53M
수익:
-
순이익/손실:
$-19.09M
주가수익비율:
-0.1699
EPS:
-2.06
순현금흐름:
$-16.92M
1주 성능:
-3.87%
1개월 성능:
-24.26%
6개월 성능:
-66.03%
1년 성능:
-72.23%
1일 변동 폭
$0.321
$0.3599
1주일 범위
$0.3154
$0.435
52주 변동 폭
$0.3154
$1.74
Organovo Holdings Inc Stock (ONVO) Company Profile
명칭
Organovo Holdings Inc
전화
858-224-1000
주소
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
ONVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ONVO | 0.3499 | 5.53M | 0 | -19.09M | -16.92M | -2.06 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-12-13 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | 개시 | Raymond James | Outperform |
| 2015-08-11 | 다운그레이드 | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | 개시 | Jefferies | Buy |
| 2015-06-29 | 개시 | Piper Jaffray | Overweight |
모두보기
Organovo Holdings Inc 주식(ONVO)의 최신 뉴스
ONVOOrganovo Holdings Inc. Latest Stock News & Market Updates - StockTitan
Organovo reports positive Phase 2 results for liver drug FXR314 By Investing.com - Investing.com South Africa
Organovo reports positive Phase 2 results for liver drug FXR314 - Investing.com India
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - The Manila Times
Organovo's FXR314 Shows Significant Liver Fat Reduction in Phase 2 MASH Trial | ONVO Stock News - StockTitan
Human Liver Models Market 2024-2031| Emerging Technologies, - openPR
Organovo stock plunges to 52-week low of $0.35 amid market challenges - Investing.com India
3D Bioprinting Market Projected to Reach $$$ Billion by 2031 with - openPR
Armistice Capital, LLC Increases Stake in Organovo Holdings Inc - GuruFocus.com
Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight - GlobeNewswire Inc.
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases - The Manila Times
Organovo's FXR314 Drug Trial Data Selected for Major Liver Conference Presentation | ONVO Stock News - StockTitan
3D Printer Market to Grow by USD 30 Billion (2024-2028), Driven by Rising Consumer Demand for Customized Products, AI-Powered Report Highlights Market TransformationTechnavio - The Malaysian Reserve
Is Health Care's Hottest Stock a Mirage? - AOL
Organovo: Fiscal Q2 Earnings Snapshot - San Antonio Express-News
Organovo Holdings Inc (ONVO) Quarterly 10-Q Report - Quartzy
Organovo stock plunges to 52-week low of $0.39 amid market challenges - Investing.com
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Organovo stock plunges to 52-week low of $0.42 amid market challenges - Investing.com Canada
Organovo (NASDAQ:ONVO) Receives New Coverage from Analysts at StockNews.com - Defense World
How Quickly Can Organovo Holdings Generate Revenue? - AOL
Organovo stock hits 52-week low at $0.43 amid market challenges - Investing.com Australia
Organovo stock hits 52-week low at $0.43 amid market challenges By Investing.com - Investing.com South Africa
Organovo Holdings (FRA:4OR1) Peter Lynch Fair Value : €-19.81 (As of Oct. 09, 2024) - GuruFocus.com
3D Bioprinting Technologies Market Outlook 2024-2031: Trends - openPR
Organovo stock plunges to 52-week low of $0.5 amid market challenges - Investing.com Australia
Analyzing Organovo (NASDAQ:ONVO) & Turnstone Biologics (NASDAQ:TSBX) - Defense World
3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire
3D Bioprinting For Regenerative Medicine Market Focusing On - openPR
3D Printing Metals Market is set for a Potential Growth Worldwide: Hoganas, Organovo, Ponoko - Talented India
Human Liver Models Market to Witness Huge Growth by 2031 - openPR
Organovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.com - Defense World
Organovo Holdings (LTS:0R02) GF Value Rank : 0 (As of Aug. 17, 2024) - GuruFocus.com
Organovo Holdings (LTS:0R02) Price-to-Operating-Cash-Flow : (As of Aug. 17, 2024) - GuruFocus.com
Organovo Holdings (LTS:0R02) Financial Strength : 3 (As of Jun. 2024) - GuruFocus.com
Organovo Holdings (STU:4OR1) Float Percentage Of Total Shar - GuruFocus.com
Organovo Holdings (STU:4OR1) EV-to-Revenue : 49.10 (As of Aug. 16, 2024) - GuruFocus.com
3D Bioprinting Market Giants Spending Is Going To Boom | Envisiontec, Organovo Holdings, Cellink Global - Newstrail
Organovo grants stock options to executive chairman - Investing.com India
Organovo Holdings Grants Stock Options to Executive Chairman - TipRanks
Organovo Holdings, Inc. Forecasted to Post Q2 2025 Earnings of ($0.26) Per Share (NASDAQ:ONVO) - Defense World
3D Printing Metals Market Is Booming Worldwide | Hoganas, Organovo, Ponoko - openPR
Organovo stock hits 52-week low at $0.51 amid market challenges - Investing.com
Understand the 3D Bioprinting Market’s Future CAGR of 12.95%: Key Drivers, Innovations, and Insights to 203... - WhaTech
3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio - The Malaysian Reserve
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
Organovo Holdings hits 52-week low, trading at 0.55 USD - Investing.com
Organovo Holdings hits 52-week low, trading at 0.55 USD By Investing.com - Investing.com Nigeria
3D Bioprinting Market Trends and Regional Analysis | Organovo Holdings Inc. (U.S.), Cellink AB (Sweden), Stratasys Ltd. (U.S.) – Economica - Economica
3D Printing Medical Devices Market Is Booming Worldwide | Fluicell, Organovo, Renishaw - openPR
Organovo Holdings Inc (ONVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
3.55%
자본화:
|
볼륨(24시간):